CO2017006496A2 - Bacteriófago de e. coli enteroinvasiva esc-cop-4 para inhibir la proliferación de e. coli enteroinvasiva - Google Patents
Bacteriófago de e. coli enteroinvasiva esc-cop-4 para inhibir la proliferación de e. coli enteroinvasivaInfo
- Publication number
- CO2017006496A2 CO2017006496A2 CONC2017/0006496A CO2017006496A CO2017006496A2 CO 2017006496 A2 CO2017006496 A2 CO 2017006496A2 CO 2017006496 A CO2017006496 A CO 2017006496A CO 2017006496 A2 CO2017006496 A2 CO 2017006496A2
- Authority
- CO
- Colombia
- Prior art keywords
- enteroinvasive
- coli
- bacteriophage
- esc
- cop
- Prior art date
Links
- 241000588724 Escherichia coli Species 0.000 title abstract 5
- 241001515965 unidentified phage Species 0.000 title abstract 5
- 230000035755 proliferation Effects 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 241000701553 Myoviridae Species 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/40—Viruses, e.g. bacteriophages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/42—Preservation of non-alcoholic beverages
- A23L2/44—Preservation of non-alcoholic beverages by adding preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F3/00—Biological treatment of water, waste water, or sewage
- C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/02—Non-contaminated water, e.g. for industrial water supply
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2303/00—Specific treatment goals
- C02F2303/04—Disinfection
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2305/00—Use of specific compounds during water treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10131—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Mycology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Water Supply & Treatment (AREA)
- Environmental & Geological Engineering (AREA)
- Biodiversity & Conservation Biology (AREA)
- Hydrology & Water Resources (AREA)
Abstract
La presente invención se refiere a un bacteriófago aislado de la naturaleza que infecta y destruye E. coli enteroinvasiva, y un método para prevenir y tratar las infecciones de E. coli enteroinvasiva mediante el uso de una composición que comprende el bacteriófago como un ingrediente activo. Más particularmente, la presente invención se refiere a un bacteriófago Myoviridae Esc-COP-4 que se aísla de la naturaleza y puede destruir específicamente cepas de E. coli enteroinvasiva, el cual tiene un genoma representado por la secuencia de nucleótidos de la sec. con núm. de ident.: 1 (número de registro en el KCTC 12663BP), y un método para prevenir las infecciones de E. coli enteroinvasiva y después de eso tratar mediante el uso de la composición que comprende dicho bacteriófago como un ingrediente activo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140192984A KR101761581B1 (ko) | 2014-12-30 | 2014-12-30 | 신규한 장침입성 대장균 박테리오파지 Esc-COP-4 및 이의 장침입성 대장균 증식 억제 용도 |
PCT/KR2015/014332 WO2016108542A1 (ko) | 2014-12-30 | 2015-12-28 | 신규한 장침입성 대장균 박테리오파지 Esc-COP-4 및 이의 장침입성 대장균 증식 억제 용도 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2017006496A2 true CO2017006496A2 (es) | 2017-09-20 |
Family
ID=56284614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2017/0006496A CO2017006496A2 (es) | 2014-12-30 | 2017-06-27 | Bacteriófago de e. coli enteroinvasiva esc-cop-4 para inhibir la proliferación de e. coli enteroinvasiva |
Country Status (8)
Country | Link |
---|---|
US (1) | US10265356B2 (es) |
KR (1) | KR101761581B1 (es) |
CN (1) | CN107208067B (es) |
BR (1) | BR112017013245A2 (es) |
CO (1) | CO2017006496A2 (es) |
MX (1) | MX2017008562A (es) |
RU (1) | RU2662984C1 (es) |
WO (1) | WO2016108542A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101761573B1 (ko) * | 2014-12-29 | 2017-07-26 | 주식회사 인트론바이오테크놀로지 | 신규한 장출혈성 대장균 박테리오파지 Esc-CHP-1 및 이의 장출혈성 대장균 증식 억제 용도 |
KR101761581B1 (ko) * | 2014-12-30 | 2017-07-26 | 주식회사 인트론바이오테크놀로지 | 신규한 장침입성 대장균 박테리오파지 Esc-COP-4 및 이의 장침입성 대장균 증식 억제 용도 |
KR101761578B1 (ko) * | 2014-12-30 | 2017-07-26 | 주식회사 인트론바이오테크놀로지 | 신규한 장병원성 대장균 박테리오파지 Esc-CHP-2 및 이의 장병원성 대장균 증식 억제 용도 |
KR101649851B1 (ko) * | 2014-12-30 | 2016-08-30 | 주식회사 인트론바이오테크놀로지 | 신규한 시가독소생산 F18형 대장균 박테리오파지 Esc-COP-1 및 이의 시가독소생산 F18형 대장균 증식 억제 용도 |
US11058131B2 (en) | 2015-04-16 | 2021-07-13 | Kennesaw State University Research And Service Foundation, Inc. | Escherichia coli O157:H7 bacteriophage Φ241 |
KR20180061774A (ko) | 2016-11-30 | 2018-06-08 | 주식회사 인트론바이오테크놀로지 | 대장균 박테리오파지 Esc-COP-7 및 이의 병원성 대장균 증식 억제 용도 |
KR102073094B1 (ko) * | 2018-06-04 | 2020-02-04 | (주)인트론바이오테크놀로지 | 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-3 및 이의 스트렙토코커스 수이스 균 증식 억제 용도 |
US11583565B2 (en) * | 2020-04-04 | 2023-02-21 | Intron Biotechnology, Inc. | Compositions and methods for inhibiting the proliferation of pathogenic Escherichia coli |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003054173A1 (en) * | 2001-12-13 | 2003-07-03 | Societe Des Produits Nestle S.A. | Isolated phages and their use in food or pet food products |
KR100781669B1 (ko) | 2006-06-20 | 2007-12-03 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균 특이적 사멸능을 갖는 박테리오파지 |
NZ579002A (en) | 2007-03-02 | 2012-03-30 | Danisco | Cultures with improved phage resistance |
KR101016918B1 (ko) | 2009-01-08 | 2011-02-25 | 주식회사 인트론바이오테크놀로지 | 박테리아 특이적 넓은 항균 활성을 갖는 신규한 리신 단백질 |
US8846368B2 (en) * | 2009-09-03 | 2014-09-30 | Cj Cheiljedang Corporation | Bacteriophage and antibacterial composition comprising the same |
KR101101376B1 (ko) * | 2009-10-16 | 2012-01-02 | 경희대학교 산학협력단 | 대장균 또는 시겔라속 균에 특이적 사멸능을 갖는 박테리오파지 |
KR101275263B1 (ko) * | 2011-04-01 | 2013-06-14 | 서울대학교산학협력단 | 조류 병원성 대장균 특이 박테리오파지 및 이를 포함하는 항균 조성물 |
US20130011369A1 (en) | 2011-07-05 | 2013-01-10 | Intron Biotechnology, Inc. | Method for Prevention and Treatment of Salmonella Infection |
KR101260645B1 (ko) * | 2011-11-14 | 2013-05-03 | 씨제이제일제당 (주) | 대장균 특이적 사멸능을 나타내는 신규 분리된 박테리오파지 및 이를 포함하는 항균 조성물 |
US9504721B2 (en) | 2012-06-04 | 2016-11-29 | Ctc Bio, Inc. | Bacteriophage and its use for preventing proliferation of pathogenic bacteria |
KR101509186B1 (ko) * | 2013-05-29 | 2015-04-08 | 서울여자대학교 산학협력단 | 위치정보기반의 가상요금소 설정 및 통행료 지불 시스템 및 그 방법 |
KR20140140698A (ko) | 2013-05-30 | 2014-12-10 | 한국외국어대학교 연구산학협력단 | 에세리키아 콜라이의 박테리오파아지 및 그 용도 |
KR101581654B1 (ko) | 2013-06-27 | 2015-12-31 | 주식회사 인트론바이오테크놀로지 | K99형 대장균 감염을 방지 및 처치하는 방법 |
KR101590108B1 (ko) * | 2014-04-10 | 2016-01-29 | 씨제이제일제당(주) | 신규 박테리오파지 및 이를 포함하는 조성물 |
KR101591795B1 (ko) * | 2014-04-15 | 2016-02-04 | 씨제이제일제당(주) | 신규 박테리오파지 및 이를 포함하는 조성물 |
KR101591793B1 (ko) * | 2014-04-15 | 2016-02-04 | 씨제이제일제당(주) | 신규 박테리오파지 및 이를 포함하는 조성물 |
KR101592177B1 (ko) * | 2014-05-07 | 2016-02-05 | 주식회사 인트론바이오테크놀로지 | 대장균에 대한 광범위 항균 활성을 갖는 박테리오파지를 활용한 대장균 감염을 방지 및 처치하는 방법 |
KR101649849B1 (ko) * | 2014-12-29 | 2016-08-22 | 주식회사 인트론바이오테크놀로지 | 신규한 클로스트리디움 퍼프린젠스 박테리오파지 Clo-PEP-1 및 이의 클로스트리디움 퍼프린젠스 증식 억제 용도 |
KR101761573B1 (ko) * | 2014-12-29 | 2017-07-26 | 주식회사 인트론바이오테크놀로지 | 신규한 장출혈성 대장균 박테리오파지 Esc-CHP-1 및 이의 장출혈성 대장균 증식 억제 용도 |
KR101649851B1 (ko) * | 2014-12-30 | 2016-08-30 | 주식회사 인트론바이오테크놀로지 | 신규한 시가독소생산 F18형 대장균 박테리오파지 Esc-COP-1 및 이의 시가독소생산 F18형 대장균 증식 억제 용도 |
KR101761581B1 (ko) * | 2014-12-30 | 2017-07-26 | 주식회사 인트론바이오테크놀로지 | 신규한 장침입성 대장균 박테리오파지 Esc-COP-4 및 이의 장침입성 대장균 증식 억제 용도 |
KR101761578B1 (ko) * | 2014-12-30 | 2017-07-26 | 주식회사 인트론바이오테크놀로지 | 신규한 장병원성 대장균 박테리오파지 Esc-CHP-2 및 이의 장병원성 대장균 증식 억제 용도 |
KR101676621B1 (ko) * | 2015-01-16 | 2016-11-16 | 주식회사 인트론바이오테크놀로지 | 신규한 락토코커스 가르비에 박테리오파지 Lac-GAP-1 및 이의 락토코커스 가르비에 균 증식 억제 용도 |
KR101679548B1 (ko) | 2015-01-28 | 2016-12-06 | 주식회사 인트론바이오테크놀로지 | 신규한 락토바실러스 브레비스 박테리오파지 Lac-BRP-1 및 이의 락토바실러스 브레비스 균 증식 억제 용도 |
KR101679549B1 (ko) | 2015-01-29 | 2016-12-06 | 주식회사 인트론바이오테크놀로지 | 신규한 락토바실러스 플랜타룸 박테리오파지 Lac-PLP-1 및 이의 락토바실러스 플랜타룸 균 증식 억제 용도 |
KR101699245B1 (ko) * | 2015-12-21 | 2017-02-13 | 주식회사 인트론바이오테크놀로지 | 신규한 파스튜렐라 멀토시다 박테리오파지 Pas-MUP-1 및 이의 파스튜렐라 멀토시다 균 증식 억제 용도 |
WO2017223101A1 (en) * | 2016-06-22 | 2017-12-28 | The United States Of America As Represented By The Secretary Of The Navy | Bacteriophage compositions and methods of selection of components against specific bacteria |
KR20180061774A (ko) * | 2016-11-30 | 2018-06-08 | 주식회사 인트론바이오테크놀로지 | 대장균 박테리오파지 Esc-COP-7 및 이의 병원성 대장균 증식 억제 용도 |
-
2014
- 2014-12-30 KR KR1020140192984A patent/KR101761581B1/ko active IP Right Grant
-
2015
- 2015-12-28 WO PCT/KR2015/014332 patent/WO2016108542A1/ko active Application Filing
- 2015-12-28 RU RU2017121452A patent/RU2662984C1/ru active
- 2015-12-28 MX MX2017008562A patent/MX2017008562A/es unknown
- 2015-12-28 CN CN201580071157.6A patent/CN107208067B/zh active Active
- 2015-12-28 BR BR112017013245A patent/BR112017013245A2/pt not_active Application Discontinuation
- 2015-12-28 US US15/538,588 patent/US10265356B2/en active Active
-
2017
- 2017-06-27 CO CONC2017/0006496A patent/CO2017006496A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR101761581B1 (ko) | 2017-07-26 |
KR20160080577A (ko) | 2016-07-08 |
BR112017013245A2 (pt) | 2018-08-07 |
CN107208067B (zh) | 2020-09-11 |
RU2662984C1 (ru) | 2018-07-31 |
MX2017008562A (es) | 2017-10-26 |
US10265356B2 (en) | 2019-04-23 |
US20170333499A1 (en) | 2017-11-23 |
CN107208067A (zh) | 2017-09-26 |
WO2016108542A1 (ko) | 2016-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017006494A2 (es) | Bacteriófago clo-pep-1 de clostridium perfringens para inhibir la proliferación de clostridium perfringens | |
CO2017006496A2 (es) | Bacteriófago de e. coli enteroinvasiva esc-cop-4 para inhibir la proliferación de e. coli enteroinvasiva | |
CO2017006495A2 (es) | Bacteriófago esc-cop-1 de e. coli tipo f18 productora de toxina shiga para inhibir la proliferación de e. coli tipo f18 productora de toxina shiga | |
CO2018006947A2 (es) | Novedoso bacteriófago pas-mup-1 de pasteurella multocida y su uso para inhibir la proliferación de pasteurella multocida | |
CO2018010459A2 (es) | Composiciones que comprenden cepas bacterianas | |
EA030115B9 (ru) | Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b | |
PH12016502564A1 (en) | Substituted nucleosides, nucleosides and analogs thereof | |
EA201791460A1 (ru) | N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения | |
CL2016001811A1 (es) | Compuestos heterociclos derivados de 3-(azepan-1-il-sulfonil)-n-fenilbenzamida; composición farmacéutica, útiles para tratar y prevenir la infección por vhb | |
CO2019010062A2 (es) | Novedoso bacteriófago clo-pep-2 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens | |
BR112017013028A2 (pt) | nucleosídeos, nucleotídeos e análogos dos mesmos substituídos | |
PH12016502001A1 (en) | Novel bacteriophage and composition comprising same | |
PH12016502003A1 (en) | Novel bacteriophage and composition containing same | |
BR112016024096A2 (pt) | novo bacteriófago e composição compreendendo o mesmo | |
PH12016501999A1 (en) | Novel bacteriophage and composition containing same | |
BR112018069974A2 (pt) | compostos de tiazolida para o tratamento de infecções virais | |
CL2022000531A1 (es) | Composiciones y métodos para el tratamiento de infecciones virales. | |
CR20160178A (es) | Derivados de desoxinojirimicina y sus métodos de uso | |
CL2017000151A1 (es) | Derivados de piridona | |
PE20170185A1 (es) | Composiciones farmaceuticas para tratar enfermedades infecciosas | |
MX2018016037A (es) | Variantes de lipasa y composiciones que comprenden tensioactivo y variante de lipasa. | |
PH12016502000A1 (en) | Novel bacteriophage and composition comprising same | |
CO2020010533A2 (es) | Novedoso bacteriófago de salmonella heidelberg sal-hep-1 y su uso para inhibir el crecimiento de las bacterias de salmonella heidelberg | |
PH12017500820A1 (en) | Combination long acting compositions and methods for hepatitis c | |
WO2018101595A3 (ko) | 대장균 박테리오파지 Esc-COP-9 및 이의 병원성 대장균 증식 억제 용도 |